Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Market Cap	32.03M
Revenue (ttm)	34.95M
Net Income (ttm)	-40.10M
Shares Out	84.96M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	48,328
Open	37.00
Previous Close	37.70
Day's Range	37.00 - 37.00
52-Week Range	26.60 - 47.50
Beta	1.07
RSI	45.90
Earnings Date	Aug 21, 2025

About TLV:TKUN

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 19
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TKUN

Financial Performance

In 2024, TLV:TKUN's revenue was 34.95 million, a decrease of -20.97% compared to the previous year's 44.23 million. Losses were -40.10 million, -54.88% less than in 2023.